annual cash & cash equivalents:
$94.82M-$130.13M(-57.85%)Summary
- As of today (May 19, 2025), TARS annual cash & cash equivalents is $94.82 million, with the most recent change of -$130.13 million (-57.85%) on December 31, 2024.
- During the last 3 years, TARS annual cash & cash equivalents has fallen by -$76.51 million (-44.66%).
- TARS annual cash & cash equivalents is now -57.85% below its all-time high of $224.95 million, reached on December 31, 2023.
Performance
TARS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$175.79M+$80.97M(+85.39%)Summary
- As of today (May 19, 2025), TARS quarterly cash & cash equivalents is $175.79 million, with the most recent change of +$80.97 million (+85.39%) on March 31, 2025.
- Over the past year, TARS quarterly cash & cash equivalents has dropped by -$17.92 million (-9.25%).
- TARS quarterly cash & cash equivalents is now -28.36% below its all-time high of $245.36 million, reached on June 30, 2022.
Performance
TARS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TARS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.9% | -9.3% |
| 3 y3 years | -44.7% | +0.4% |
| 5 y5 years | +63.6% | - |
TARS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.9% | +32.3% | -28.4% | +166.4% |
| 5 y | 5-year | -57.9% | +63.6% | -28.4% | +230.8% |
| alltime | all time | -57.9% | +3926.3% | -28.4% | +230.8% |
TARS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $175.79M(+85.4%) |
| Dec 2024 | $94.82M(-57.8%) | $94.82M(-46.2%) |
| Sep 2024 | - | $176.21M(-2.7%) |
| Jun 2024 | - | $181.09M(-6.5%) |
| Mar 2024 | - | $193.71M(-13.9%) |
| Dec 2023 | $224.95M(+213.9%) | $224.95M(-0.8%) |
| Sep 2023 | - | $226.67M(+112.3%) |
| Jun 2023 | - | $106.77M(+61.8%) |
| Mar 2023 | - | $66.00M(-7.9%) |
| Dec 2022 | $71.66M | $71.66M(-57.7%) |
| Sep 2022 | - | $169.49M(-30.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $245.36M(+40.2%) |
| Mar 2022 | - | $175.01M(+2.1%) |
| Dec 2021 | $171.33M(+1.9%) | $171.33M(-6.8%) |
| Sep 2021 | - | $183.80M(+4.0%) |
| Jun 2021 | - | $176.74M(+13.2%) |
| Mar 2021 | - | $156.18M(-7.1%) |
| Dec 2020 | $168.13M(+190.1%) | $168.13M(+94.8%) |
| Sep 2020 | - | $86.33M(+62.5%) |
| Jun 2020 | - | $53.13M(-8.3%) |
| Dec 2019 | $57.95M(+2360.8%) | $57.95M |
| Dec 2018 | $2.35M | - |
FAQ
- What is Tarsus Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Tarsus Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Tarsus Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of TARS is $94.82M
What is the all time high annual cash & cash equivalents for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual cash & cash equivalents is $224.95M
What is Tarsus Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, TARS annual cash & cash equivalents has changed by -$130.13M (-57.85%)
What is Tarsus Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TARS is $175.79M
What is the all time high quarterly cash & cash equivalents for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly cash & cash equivalents is $245.36M
What is Tarsus Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, TARS quarterly cash & cash equivalents has changed by -$17.92M (-9.25%)